XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Assets and Liabilities (Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Assets    
Total investments at fair value $ 1,024,951,000 $ 1,076,840,000
Cash and cash equivalents 5,960,000 5,751,000
Interest and fees receivable 8,873,000 8,141,000
Other assets 1,473,000 623,000
Total assets 1,041,257,000 1,091,355,000
Liabilities    
Credit facility 259,000,000 311,000,000
Unamortized deferred financing costs (7,302,000) (5,918,000)
Total debt, less unamortized deferred financing costs 515,948,000 552,332,000
Incentive fees payable 14,491,000 14,106,000
Interest payable 8,190,000 7,743,000
Foreign currency forward contracts 1,359,000 [1] 0
Accrued expenses and other liabilities 2,395,000 2,305,000
Total liabilities 542,383,000 576,486,000
Commitments and contingencies (Note 8)
Net assets    
Common stock, par value 365,000 373,000
Additional paid-in capital 549,859,000 557,992,000
Accumulated undistributed (overdistributed) earnings (51,350,000) (43,496,000)
Total net assets $ 498,874,000 $ 514,869,000
Shares of common stock outstanding ($0.01 par value, 100,000,000 shares authorized) 36,532,020 37,347,428
Net asset value per share $ 13.66 $ 13.79 [2]
2026 Notes    
Liabilities    
Notes $ 25,000,000 $ 95,000,000
2027 Notes    
Liabilities    
Notes 132,250,000 152,250,000
2028 Notes    
Liabilities    
Notes 107,000,000 0
Non-control/non-affiliate investments    
Assets    
Total investments at fair value 1,017,952,000 1,005,328,000
Affiliate investments    
Assets    
Total investments at fair value   64,572,000
Control Investments    
Assets    
Total investments at fair value $ 6,999,000 [3] $ 6,940,000 [4]
[1] Net amount of derivative liabilities represents the net amount due from the Company to the counterparty.
[2] All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period.
[3] All affiliate and control investments, which as of June 30, 2025, represented 1.40% of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors.
[4] All affiliate and control investments, which as of December 31, 2024, represented 13.90% of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors.